Growth Metrics

Idexx Laboratories (IDXX) Operating Leases: 2019-2025

Historic Operating Leases for Idexx Laboratories (IDXX) over the last 7 years, with Sep 2025 value amounting to $133.1 million.

  • Idexx Laboratories' Operating Leases rose 7.04% to $133.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.1 million, marking a year-over-year increase of 7.04%. This contributed to the annual value of $97.8 million for FY2024, which is 1.84% down from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Operating Leases is $133.1 million, which was down 0.24% from $133.5 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Operating Leases ranged from a high of $133.5 million in Q2 2025 and a low of $87.4 million during Q4 2021.
  • Moreover, its 3-year median value for Operating Leases was $121.4 million (2023), whereas its average is $119.1 million.
  • In the last 5 years, Idexx Laboratories' Operating Leases grew by 26.44% in 2021 and then declined by 3.28% in 2025.
  • Over the past 5 years, Idexx Laboratories' Operating Leases (Quarterly) stood at $87.4 million in 2021, then increased by 15.86% to $101.2 million in 2022, then declined by 1.55% to $99.7 million in 2023, then declined by 1.84% to $97.8 million in 2024, then rose by 7.04% to $133.1 million in 2025.
  • Its Operating Leases was $133.1 million in Q3 2025, compared to $133.5 million in Q2 2025 and $119.1 million in Q1 2025.